# Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

> **NCT00442780** · PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 36 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** BIIB014
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00442780
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2009-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442780, "Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00442780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*